CCR9 and malignant colon neoplasm: Remarkably, the CD4/CD8 ratio, which indicates the immune state [41], is significantly lower in the tumor and peri-tumoral zone of CCR9−/−, suggesting that CCR9 expression controls the immune balance in colon cancer, and showing an enrichment of CD8+ T cells when CCR9 is absent (Fig 3D).